Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - AMICUS THERAPEUTICS, INC. | a2231065zex-31_1.htm |
EX-32.2 - EX-32.2 - AMICUS THERAPEUTICS, INC. | a2231065zex-32_2.htm |
EX-32.1 - EX-32.1 - AMICUS THERAPEUTICS, INC. | a2231065zex-32_1.htm |
EX-31.2 - EX-31.2 - AMICUS THERAPEUTICS, INC. | a2231065zex-31_2.htm |
EX-21 - EX-21 - AMICUS THERAPEUTICS, INC. | a2231065zex-21.htm |
10-K - 10-K - AMICUS THERAPEUTICS, INC. | a2231065z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
- 1.
- Registration
Statement (Form S-3ASR No. 333-212414) pertaining to the Amicus Therapeutics, Inc., Automatic shelf registration statement of
securities of well-known seasoned issuers
- 2.
- Registration
Statement (Form S-3ASR No. 333-211005) pertaining to the Amicus Therapeutics, Inc., Automatic shelf registration statement of
securities of well-known seasoned issuers
- 3.
- Registration
Statement (Form S-3ASR No. 333-207210) pertaining to the Amicus Therapeutics, Inc., Automatic shelf registration statement of
securities of well-known seasoned issuers
- 4.
- Registration
Statement (Form S-8 No. 333-197202) pertaining to the Amicus Therapeutics, Inc. Cash Deferral Plan,
- 5.
- Registration
Statement (Form S-8 No. 333-195194) pertaining to the Amicus Therapeutics, Inc. Restricted Stock Unit Deferral Plan,
- 6.
- Registration
Statement (Form S-8 No. 333-145305) pertaining to the: 1) Amicus Therapeutics, Inc. 2002 Equity Incentive Plan, as Amended,
2) Amicus Therapeutics, Inc. 2007 Equity Incentive Plan, 3) Amicus Therapeutics, Inc. 2007 Director Option Plan, 4) Amicus Therapeutics, Inc. 2007 Employee
Stock Purchase Plan,
- 7.
- Registration
Statement (Form S-8 No. 333-157219) pertaining to the: 1) Amicus Therapeutics, Inc. Amended and Restated 2007 Equity
Incentive Plan and 2) Amicus Therapeutics, Inc. 2007 Director Option Plan,
- 8.
- Registration Statement (Form S-8 No. 333-174900) pertaining to the: 1) Amicus Therapeutics, Inc. Amended and Restated 2007 Equity Incentive Plan and 2) Amicus Therapeutics, Inc. Amended and Restated 2007 Director Option Plan,
of our reports dated March 1, 2017 with respect to the consolidated financial statements of Amicus Therapeutics, Inc., and the effectiveness of internal control over financial reporting of Amicus Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2016.
/s/
Ernst & Young LLP
Iselin,
New Jersey
March 1, 2017
Consent of Independent Registered Public Accounting Firm